HomeOVID • NASDAQ
add
Ovid Therapeutics Inc
Previous close
$3.15
Day range
$3.04 - $3.14
Year range
$2.57 - $4.14
Market cap
217.43M USD
Avg Volume
272.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 141.56K | 205.88% |
Operating expense | 19.93M | 54.27% |
Net income | -15.32M | -33.18% |
Net profit margin | -10.82K | 56.46% |
Earnings per share | -0.22 | — |
EBITDA | -19.65M | -54.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 105.83M | -17.96% |
Total assets | 144.03M | -7.24% |
Total liabilities | 56.23M | 144.55% |
Total equity | 87.80M | — |
Shares outstanding | 70.71M | — |
Price to book | 2.54 | — |
Return on assets | -36.77% | — |
Return on capital | -44.69% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -15.32M | -33.18% |
Cash from operations | -11.91M | -29.82% |
Cash from investing | -48.52M | -1,063.59% |
Cash from financing | 30.03M | 68,985.51% |
Net change in cash | -30.40M | -127.02% |
Free cash flow | -6.51M | -9.40% |
About
Founded
2014
Website
Employees
40